Found 21 matching trials
Boceprevir Treatment in Liver Pre-transplant HCV Patients PHASE3 End-stage liver disease due to hepatitis C virus (HCV) is the most common i...
Show More Location
123, Ta Pei Road, Niao Sung Hsiang
Learn More & Join Trial
Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection PHASE3 Hepatitis C virus (HCV) infection is a leading cause of death and illness i...
Show More Learn More & Join Trial
Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy PHASE4 The purpose of this study is to evaluate the impact of a physician directed...
Show More Location
California Liver Institute
Learn More & Join Trial
Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy N/A The hypothesis was to check whether baseline anti-E1E2 antibodies were corr...
Show More Location
Hôpital de la Croix Rousse
Learn More & Join Trial
Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation PHASE2 Evaluation of efficacy of triple therapy with pegylated interferon, ribavir...
Show More Location
Haut-Lévêque Hospital
Learn More & Join Trial
An Observational Study Examining the Use of Triple Combination Therapy With Boceprevir, Peginterferon Alfa-2a and Ribavirin in the Re-Treatment of Chronic Hepatitis C Patients N/A This prospective, national, multicenter, non-interventional study examined ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Boceprevir in Asia Pacific Participants With Chronic Hepatitis C Genotype 1 (P07063) PHASE3 This study will assess the efficacy of boceprevir (BOC) in combination with...
Show More Location
Multiple Locations
Learn More & Join Trial
Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC) PHASE3 The cohort of post-menopausal women represents a group of very-difficult-to...
Show More Location
Gastroenterology Unit
Learn More & Join Trial
Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients N/A The purpose of this study is to evaluate the efficacy and tolerability of D...
Show More Location
Valme University Hospital
Learn More & Join Trial
Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Boceprevir/Pegylated Interferon/Ribavarin for Chronic Hepatitis C Infection (MK-5172-066) PHASE3 This is a randomized, multi-site, open-label trial of a fixed-dose combinat...
Show More Location
Multiple Locations
Learn More & Join Trial